Literature DB >> 26929437

High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?

Victor V Lima1, Fernanda R Giachini2, Takayuki Matsumoto3, Weiguo Li4, Alecsander F M Bressan2, Dhruv Chawla4, R Clinton Webb4, Adviye Ergul4, Rita C Tostes5.   

Abstract

Obesity and high fat intake induce alterations in vascular function and structure. Aberrant O-GlcNAcylation (O-GlcNAc) of vascular proteins has been implicated in vascular dysfunction associated with cardiovascular and metabolic diseases. In the present study, we tested the hypothesis that high-fat diet (HFD)-mediated increases in O-GlcNAc-modified proteins contribute to cerebrovascular dysfunction. O-GlcNAc-protein content was increased in arteries from male Wistar rats treated with a HFD (45% fat) for 12 weeks compared with arteries from rats on control diet (CD). HFD augmented body weight [(g) 550±10 compared with 502±10 CD], increased plasma triacylglycerols [(mg/dl) 160±20 compared with 95±15 CD] and increased contractile responses of basilar arteries to serotonin [5-hydroxytryptamine (5-HT)] [(pD2) 7.0±0.1 compared with 6.7±0.09 CD] and the thromboxane analogue 9,11-dideoxy-9α,11α-methanoepoxy prostaglandin F2α (U-46619) [(pD2) 7.2±0.1 compared with 6.8±0.09 CD]. Of importance, increased levels of O-GlcNAc [induced by 24 h-incubation of vessels with a potent inhibitor of O-GlcNAcase (OGA), O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PugNAc)] increased basilar artery contractions in response to U-46619 [(pD2) 7.4±0.07 compared with 6.8±0.08 CD] and 5-HT [(pD2) 7.5±0.06 compared with 7.1±0.1 CD]. Vessels from rats on the HFD for 12 weeks and vessels treated with PugNAc displayed increased phosphorylation of p38 (Thr(180/182)) and extracellular signal-regulated kinase 1/2 (Erk1/2) (Ser(180/221)). Increased 5HT-induced contractions in arteries from rats on the HFD or in arteries incubated with PugNAc were abrogated by mitogen-activated protein kinase (MAPK) inhibitors. Our data show that HFD augments cerebrovascular O-GlcNAc and this modification contributes to increased contractile responses and to the activation of the MAPK pathway in the rat basilar artery.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  O-GlcNAc; basilar artery; cerebral artery; high fat; vascular contraction

Mesh:

Substances:

Year:  2016        PMID: 26929437      PMCID: PMC5595355          DOI: 10.1042/CS20150777

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  44 in total

Review 1.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

Authors:  Robert G Spiro
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

2.  Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.

Authors:  Garrett E Whitworth; Matthew S Macauley; Keith A Stubbs; Rebecca J Dennis; Edward J Taylor; Gideon J Davies; Ian R Greig; David J Vocadlo
Journal:  J Am Chem Soc       Date:  2007-01-24       Impact factor: 15.419

3.  Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM.

Authors:  Victor V Lima; Fernanda R C Giachini; Fernando S Carneiro; Zidonia N Carneiro; Zuleica B Fortes; Maria Helena C Carvalho; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

4.  O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.

Authors:  Victor V Lima; Christiné S Rigsby; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2009 Nov-Dec

Review 5.  Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation.

Authors:  Ping Hu; Shino Shimoji; Gerald W Hart
Journal:  FEBS Lett       Date:  2010-04-22       Impact factor: 4.124

6.  Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.

Authors:  Christian Deutsch; Vera Portik-Dobos; Anita D Smith; Adviye Ergul; Anne M Dorrance
Journal:  Microvasc Res       Date:  2009-04-15       Impact factor: 3.514

7.  A nutrient-sensing pathway regulates leptin gene expression in muscle and fat.

Authors:  J Wang; R Liu; M Hawkins; N Barzilai; L Rossetti
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

8.  Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.

Authors:  Wagner B Dias; Win D Cheung; Zihao Wang; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

9.  Cerebral vascular dysfunction during hypercholesterolemia.

Authors:  Jiro Kitayama; Frank M Faraci; Steven R Lentz; Donald D Heistad
Journal:  Stroke       Date:  2007-05-24       Impact factor: 7.914

10.  Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells.

Authors:  Qing-wen Chen; Lars Edvinsson; Cang-Bao Xu
Journal:  BMC Cell Biol       Date:  2009-07-03       Impact factor: 4.241

View more
  13 in total

1.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

2.  High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation.

Authors:  Diogo de Barros Peruchetti; Rodrigo Pacheco Silva-Aguiar; Gabriela Marques Siqueira; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

3.  Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.

Authors:  Mingzuo Jiang; Nan Wu; Bing Xu; Yi Chu; Xiaowei Li; Song Su; Di Chen; Wenjiao Li; Yanting Shi; Xiaoliang Gao; Haohao Zhang; Zhao Zhang; Wei Du; Yongzhan Nie; Jie Liang; Daiming Fan
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 4.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

Review 5.  A nexus of lipid and O-Glcnac metabolism in physiology and disease.

Authors:  Amber Lockridge; John A Hanover
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

6.  Impaired Ca(2+) Homeostasis and Decreased Orai1 Expression Modulates Arterial Hyporeactivity to Vasoconstrictors During Endotoxemia.

Authors:  Arthur Oliveira Nonato; Vania C Olivon; Vanessa Dela Justina; Camila Z Zanotto; R Clinton Webb; Rita C Tostes; Victor V Lima; Fernanda R Giachini
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

7.  Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.

Authors:  Weiwei Dai; Sadie K Dierschke; Allyson L Toro; Michael D Dennis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-11       Impact factor: 5.187

8.  Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2.

Authors:  Amber Lockridge; Seokwon Jo; Eric Gustafson; Niklas Damberg; Ramkumar Mohan; Miranda Olson; Juan E Abrahante; Emilyn U Alejandro
Journal:  Cell Rep       Date:  2020-05-05       Impact factor: 9.423

Review 9.  O-GlcNAcylation and cardiovascular disease.

Authors:  JaLessa N Wright; Helen E Collins; Adam R Wende; John C Chatham
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

10.  Increased O-GlcNAcylation of Endothelial Nitric Oxide Synthase Compromises the Anti-contractile Properties of Perivascular Adipose Tissue in Metabolic Syndrome.

Authors:  Rafael M da Costa; Josiane F da Silva; Juliano V Alves; Thiago B Dias; Diane M Rassi; Luis V Garcia; Núbia de Souza Lobato; Rita C Tostes
Journal:  Front Physiol       Date:  2018-04-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.